Exatidão dos dados do sistema de vigilância epidemiológica da malária no estado do Amazonas

The Epidemiological Surveillance System for Malaria (SIVEP-Malaria) is the Brazilian governmental program that registers all information about compulsory reporting of detected cases of malaria by all medical units and medical practitioners. The objective of this study is to point out the main sources of errors in the SIVEP-Malaria database by applying a data cleaning method to assist researchers about the best way to use it and to report the problems to authorities. The aim of this study was to assess the quality of the data collected by the surveillance system and its accuracy. The SIVEP-Malaria data base used was for the state of Amazonas, Brazil, with data collected from 2003 to 2014. A data cleaning method was applied to the database to detect and remove erroneous records. It was observed that the collecting procedure of the database is not homogeneous among the municipalities and over the years. Some of the variables had different data collection periods, missing data, outliers and inconsistencies. Variables depending on the health agents showed a good quality but those that rely on patients were often inaccurate. We showed that a punctilious preprocessing is needed to produce statistically correct data from the SIVEP-Malaria data base. Fine spatial scale and multi-temporal analysis are of particular concern due to the local concentration of uncertainties and the data collecting seasonality observed. This assessment should help to enhance the quality of studies and the monitoring of the use of the SIVEP database.O Sistema de Vigilância Epidemiológica de Malária (SIVEP-Malária) é um programa governamental brasileiro que arquiva automaticamente todas as informações sobre casos de malária registrados em todas as unidades de saúde e consultórios medicos. O objetivo deste estudo foi avaliar a qualidade dos dados coletados pelo sistema de vigilância e sua precisão. Foram utilizados os dados do SIVEP-Malária para o estado do Amazonas, Brasil, de 2003 a 2014. Um método de limpeza de dados foi aplicado para detectar e remover registros errôneos. Observamos que a coleta de dados não é homogênea entre os municipios e ao longo dos anos. Algumas variaveis tinham diferentes padrões de coleta, falta de dados, dados discrepantes e inconsistências. Dados que dependem do agente de saúde possuem boa qualidade mas aqueles que dependem dos pacientes são frequentemente imprecisos. Mostramos que um pre-processamento meticuloso é necessário para produzir dados estatisticamente corretos a partir do SIVEP-Malária. Analises em escala espacial detalhada ou multi-temporais são particularmente afetadas devido à concentração local de incertezas e a sazonalidade observada na coleta de dados. Esta avaliação deve auxiliar a melhorar os estudos e monitoramentos que fazem uso dos dados do SIVEP

Physiotherapy for Parkinson’s disease: a comparison of techniques (review)

Background: Despite optimal medical and surgical therapies for Parkinson's disease, patients develop progressive disability. The role of the physiotherapist is to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person. What form of physiotherapy is most effective in the treatment of Parkinson's disease remains unclear.Objectives: 1. To compare the efficacy and effectiveness of novel physiotherapy techniques versus 'standard' physiotherapy in patients with Parkinson's disease. Standard physiotherapy is defined as the type of therapy that the physiotherapist would usually use to treat Parkinson's disease. 2. To compare the efficacy and effectiveness of one physiotherapy technique versus a second form of physiotherapy.Search strategy: Relevant trials were identified by electronic searches of MEDLINE, EMBASE, CINAHL, ISI-SCI, AMED, MANTIS, REHABDATA, REHADAT, GEROLIT, Pascal, LILACS, MedCarib, JICST-EPlus, AIM, IMEMR, SIGLE, ISI-ISTP, DISSABS, Conference Papers Index, Aslib Index to Theses, the Cochrane Controlled Trials Register, the CentreWatch Clinical Trials listing service, the metaRegister of Controlled Trials, ClinicalTrials.gov, CRISP, PEDro, NIDRR and NRR; and examination of the reference lists of identified studies and other reviews.Selection criteria: Only randomised controlled trials (RCT) were included.Data collection and analysis: Data was abstracted independently by KD and CEH and differences settled by discussion.Main results: Seven trials were identified with 142 patients. All used small numbers of patients and the method of randomisation and concealment of allocation was poor or not stated in all of the trials. These methodological problems could potentially lead to bias from a number of sources. The methods of physiotherapy varied so widely that the data could not be combined.Authors' conclusions: Considering the small number of patients examined, the methodological flaws in many of the studies and the possibility of publication bias, there is insufficient evidence to support or refute the efficacy of any given form of physiotherapy over another in Parkinson's disease. Another Cochrane review, Physiotherapy for patients with Parkinson's Disease, found that there was insufficient evidence to support or refute the efficacy of physiotherapy compared to no physiotherapy in Parkinson's disease.A wide range of physiotherapy approaches were used in these studies and a survey of UK physiotherapists confirmed that they also use an eclectic combination of techniques in the treatment of Parkinson's disease (Plant 1999). Therefore a consensus must be found as to 'best practice' physiotherapy for Parkinson's disease.The efficacy of 'standard' physiotherapy should be proved first before examining variations in physiotherapy methods. Therefore large well designed randomised controlled trials are needed to judge the effect of physiotherapy in Parkinson's disease. After this large RCTs are needed to demonstrate the most effective form of physiotherapy in Parkinson's disease. Outcome measures with particular relevance to patients, carers, physiotherapists and physicians should be chosen and the patients monitored for at least 6 months to determine the duration of any effect. The trials should be reported according to CONSORT guidelines (CONSORT 1996)

The allosteric modulation of complement c5 by knob domain peptides

Bovines have evolved a subset of antibodies with ultra-long heavy chain complementarity determining regions that harbour cysteine-rich knob domains. To produce high-affinity peptides, we previously isolated autonomous 3–6 kDa knob domains from bovine antibodies. Here, we show that binding of four knob domain peptides elicits a range of effects on the clinically validated drug target complement C5. Allosteric mechanisms predominated, with one peptide selectively inhibiting C5 cleavage by the alternative pathway C5 convertase, revealing a targetable mechanistic difference between the classical and alternative pathway C5 convertases. Taking a hybrid biophysical approach, we present C5-knob domain co-crystal structures and, by solution methods, observed allosteric effects propagating >50 Å from the binding sites. This study expands the therapeutic scope of C5, presents new inhibitors, and introduces knob domains as new, low molecular weight antibody fragments, with therapeutic potential

The allosteric modulation of complement c5 by knob domain peptides

Bovines have evolved a subset of antibodies with ultra-long heavy chain complementarity determining regions that harbour cysteine-rich knob domains. To produce high-affinity peptides, we previously isolated autonomous 3–6 kDa knob domains from bovine antibodies. Here, we show that binding of four knob domain peptides elicits a range of effects on the clinically validated drug target complement C5. Allosteric mechanisms predominated, with one peptide selectively inhibiting C5 cleavage by the alternative pathway C5 convertase, revealing a targetable mechanistic difference between the classical and alternative pathway C5 convertases. Taking a hybrid biophysical approach, we present C5-knob domain co-crystal structures and, by solution methods, observed allosteric effects propagating >50 Å from the binding sites. This study expands the therapeutic scope of C5, presents new inhibitors, and introduces knob domains as new, low molecular weight antibody fragments, with therapeutic potential

Shigella flexneri Spa15 crystal structure verified in solution by double electron electron resonance

Shigella flexneri Spa15 is a chaperone of the type 3 secretion system, which binds a number of effectors to ensure their stabilization prior to secretion. One of these effectors is IpgB1, a mimic of the human Ras-like Rho guanosine triphosphatase RhoG. In this study, Spa15 alone and in complex with IpgB1 has been studied by double electron electron resonance, an experiment that gives distance information showing the spacial separation of attached spin labels. This distance is explained by determining the crystal structure of the spin-labeled Spa15 where labels are seen to be buried in hydrophobic pockets. The double electron electron resonance experiment on the Spa15 complex with IpgB1 shows that IpgB1 does not bind Spa15 in the same way as is seen in the homologous Salmonella sp. chaperone:effector complex InvB:SipA